// App-Quantinova.ai

: A MULTICENTER, RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Seung-Shin Lee

Principal Investigators

  • Sung-Hoon Jung

  • Mi Hwa Heo

  • Dae Sik Kim

  • Ji Hyun Lee

  • Han-Seung Park

  • Yoo Jin Lee

  • Jun Ho Yi

  • Ka-won Kang

  • Youngil Koh

  • Ho-Young Yhim

  • Jae-Cheol Jo

  • Yeung-Chul Mun

  • Won-Sik Lee

  • Deok-Hwan Yang

  • Seok Lee

Medical Centers

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of

  • Hematology/Oncology,Kyungpook National University Hospital,Daegu,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Hematology and Oncology, Ewha Womans University School of Medicine, Seoul, South Korea

  • Department of Hematology and Oncology,Korea University Guro Hospital,Seoul,Korea, Republic Of

  • Department of Urology, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A